Rating Agencies

Share recommendations

Made with ❤ von BGFL
#BGFLapp * beta

Valuable background information and well-founded assessments of individual stocks are provided by the studies of the research houses. On this page, Boersengefluester.de (BGFL) provides an integrated overview of all analyst recommendations that come in via the EQS Group newsfeed - enriched with current stock charts as well as meaningful key figure tables and investor information from BGFL. Tip: You are also welcome to use the EQS newsfeed, which we have also enhanced with all the latest company news from our coverage universe.

16.01.2024 10:02AM
Study issued by GBC AG

Cenit AG (von GBC AG): BUY

BUY
First acquisition of 2024 strengthens the 3DS Solutions division; forecasts and target price unchanged   As expected, CENIT AG is continuing the high level of acquisition activity implemented since the 2022 financial year in the 2024 financial year. As the company announced in the second calendar week of the still young year, CCE b:digital G [ … ]
15.12.2023 09:31AM
Study issued by GBC AG

HAEMATO AG (von GBC AG): suspended

suspended
Delisting of the HAEMATO share to take place from February 2023; price potential not yet exhausted; GBC-rating and GBC-price target suspended   HAEMATO has announced the termination of the inclusion of the shares in the open market of 30 November 2023. The shares are to be delisted after expiry of the notice period, at the latest by the end  [ … ]
20.11.2023 10:01AM
Study issued by GBC AG

Coreo AG (von GBC AG): BUY

BUY
H1 2023: Large portfolio acquisitions to come in 2024; EBIT break-even expected in 2024; price target: € 1.00; rating: BUY   In the first six months of 2023, Coreo AG was able to increase rental income to € 3.17 million (previous year: € 2.82 million). As there were no property additions in both the 2022 financial year and the [ … ]
03.11.2023 10:31AM
Study issued by GBC AG

Cenit AG (von GBC AG): BUY

BUY
9 months 2023: Three more companies acquired in 2023; High revenue and earnings growth achieved; Slight forecast and price target adjustment; Rating: BUY   In the third quarter of 2023, CENIT AG achieved sales growth of 9.3% to € 45.84 million (Q3 2022: € 41.95 million), thus seamlessly continuing the previous development of the cu [ … ]
02.11.2023 10:01AM
Study issued by GBC AG

Vectron Systems AG (von GBC AG): GBC Management Interview

GBC Management Interview
acardo acquisition and digitisation strategy have positive influence; risk from purchase price payment practically non-existent   After the fiscalisation effect has largely expired, Vectron Systems AG is currently in a transformation process. Their focus is on the expansion of digital services, so that in future the predominant part of Vectr [ … ]
25.10.2023 10:02AM
Study issued by GBC AG

Vectron Systems AG (von GBC AG): BUY

BUY
9 months 2023: Significant increase in sales and earnings achieved; 2023 forecasts raised and target price increased slightly; BUY   According to preliminary figures, Vectron Systems AG (short: Vectron) achieved a significant growth in turnover and result in the third quarter, which seamlessly continues the positive development of the previo [ … ]
31.03.2022 11:02AM
Study issued by GBC AG

Bitcoin Group SE (von GBC AG): BUY

BUY
Preliminary business figures 2021 - Very good development with results above our forecasts On March 29, 2022, Bitcoin Group SE published the preliminary business figures for the year 2021. Accordingly, sales increased by 56.6% to EUR23.5 million (previous year: EUR15.0 million). EBITDA increased by 85.7% to EUR19.5 million (previous year: EUR10. [ … ]
10.12.2021 12:31PM
Study issued by GBC AG

HAEMATO AG (von GBC AG): Management Interview

Management Interview
In operational terms, HAEMATO AG is heading for a record year following the acquisition of M1 Aesthetics GmbH. In addition, the expansion of their private label business is increasingly coming into focus. In this regard, the company plans to expand its portfolio with a botulinum toxin product under its own brand. GBC analyst Cosmin Filker spoke wi [ … ]

Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
We have summarised companies with a market capitalisation of more than EUR 1 billion that are not included in any index under X-Caps.
Dataselect Tool Family
          Rating Agencies          
          Qualitätsjournalismus · Made in Germany © 2024          
The news manufactory

Good luck with all your investments

Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.

Contact

Idea & concept: 3R Technologies   
boersengefluester.de GmbH Copyright © 2024 by Gereon Kruse #BGFL